Login to MyKarger

New to MyKarger? Click here to sign up.

Login with Facebook

Forgot Password? Reset your password

Authors, Editors, Reviewers

For Manuscript Submission, Check or Review Login please go to Submission Websites List.

Submission Websites List

Institutional Login (Shibboleth)

For the academic login, please select your country in the dropdown list. You will be redirected to verify your credentials.

Table of Contents
Vol. 22, No. 4, 2003
Issue release date: July – August
Section title: Invited Review
Neuroepidemiology 2003;22:217–228

An Evidence-Based Medicine Approach to the Evaluation of the Role of Exogenous Risk Factors in Sporadic Amyotrophic Lateral Sclerosis

Armon C.
Department of Neurology, Loma Linda University School of Medicine, Loma Linda, Calif., USA
email Corresponding Author

Carmel Armon, MD

Department of Neurology, Loma Linda University School of Medicine

11175 Campus Street, CP-11108

Loma Linda, CA 92354 (USA)

Tel. +1 909 5584907, Fax +1 909 5580207, E-Mail res0tna7@verizon.net


  1. Nelson LM: Epidemiology of ALS. Clin Neurosci 1995/96;3:327–331.
  2. Roman GC: Neuroepidemiology of amyotrophic lateral sclerosis: Clues to aetiology and pathogenesis. J Neurol Neurosurg Psychiatry 1996;61:131–137.
  3. Mitchell JD: Amyotrophic lateral sclerosis: Toxins and environment. Amyotroph Lateral Scler Other Motor Neuron Disord 2000;1:235–250.
  4. Armon C: Environmental risk factors for amyotrophic lateral sclerosis. Neuroepidemiology 2001;20:2–6.
  5. Noonan CW, Sykes L, Hilsdon R: Motor neuron disease/amyotrophic lateral sclerosis: Preliminary Review of Environmental Risk Factors and Mortality in Bexar County, Texas. Agency for Toxic Substances and Disease Registry (March 5, 2002) http://www.atsdr.cdc.gov/NEWS/als_032002.html
  6. Armon C, Kurland LT: Classic and Western Pacific Amyotrophic Lateral Sclerosis: Epidemiologic comparisons; in Hudson AJ (ed): Amyotrophic Lateral Sclerosis: Concepts in Etiology and Pathogenesis. Toronto, University of Toronto Press, 1990, pp 144–165.
  7. Armon C, Kurland LT, Smith GE, Steele JS: Sporadic and Western Pacific Amyotrophic Lateral Sclerosis: Epidemiologic implications; in Smith RA (ed): Handbook of Amyotrophic Lateral Sclerosis. New York, Dekker, 1992, pp 93–131.
  8. Armon C: Motor neuron disease; in Gorelick PB, Alter M (eds): Handbook of Neuroepidemiology. New York, Dekker, 1994, pp 407–456.
  9. ALSA-Funded Workshop: Meeting Report. Environmental factors and genetic susceptibility in amyotrophic lateral sclerosis. May 29–31, 2002, Keystone, Colo. http://www.alsa.org/research/workshops1.cfm
  10. Kuller LH: Circular epidemiology. Am J Epidemiol 1999;150:897–903.
  11. Hirtz D, Ashwal S, Berg A, Bettis D, Camfield C, Camfield P, Crumrine P, Elterman R, Schneider S, Shinnar S: Practice parameter: Evaluating a first nonfebrile seizure in children. Report of the Quality Standards Subcommittee of the American Academy of Neurology, The Child Neurology Society, and The American Epilepsy Society. Neurology 2000;55:616–623.
  12. Lewis DW, Ashwal S, Dahl G, Dorbad D, Hirtz D, Prensky A, Jarjour I: Practice parameter: Evaluation of children and adolescents with recurrent headaches. Report of the Quality Standards Subcommittee of the American Academy of Neurology and the Practice Committee of the Child Neurology Society. Neurology 2002;59:490–498.
  13. Hill AB: The environment and disease: Association or causation? Proc R Soc Med 1965;58:295–300.
  14. US Department of Health, Education and Welfare: Smoking and health: A report of the Surgeon General. Washington, US Government Printing Office, 1964.
  15. Armon C, Kurland LT, Daube JR, O’Brien PC: Epidemiologic correlates of sporadic amyotrophic lateral sclerosis. Neurology 1991;41:1077–1084.
  16. Chancellor AM, Slattery JM, Fraser H, Warlow CP: Risk factors for motor neuron disease: A case-control study based on patients from the Scottish Motor Neuron Disease Register. J Neurol Neurosurg Psychiatry 1993;56:1200–1206.
  17. Cruz DC, Nelson LM, McGuire V, Longstreth WT Jr: Physical trauma and family history of neurodegenerative diseases in amyotrophic lateral sclerosis: A population-based case-control study. Neuroepidemiology 1999;18:101–110.
  18. Gunnarsson LG, Lindberg G, Soderfeldt B, Axelson O: Amyotrophic lateral sclerosis in Sweden in relation to occupation. Acta Neurol Scand 1991;83:394–398.
  19. Longnecker MP, Kamel F, Umbach DM, Munsat TL, Shefner JM, Lansdell LW, Sandler DP: Dietary intake of calcium, magnesium and antioxidants in relation to risk of amyotrophic lateral sclerosis. Neuroepidemiology 2000;19:210–216.
  20. McGuire V, Longstreth WT Jr, Nelson LM, Koepsell TD, Checkoway H, Morgan MS, van Belle G: Occupational exposures and amyotrophic lateral sclerosis. A population-based case-control study. Am J Epidemiol 1997;145:1076–1088.
  21. Nelson LM, Matkin C, Longstreth WT Jr, McGuire V: Population-based case-control study of amyotrophic lateral sclerosis in western Washington State. II. Diet. Am J Epidemiol 2000;151:164–173.
  22. Schulte PA, Burnett CA, Boeniger MF, Johnson J: Neurodegenerative diseases: Occupational occurrence and potential risk factors, 1982 through 1991. Am J Public Health 1996;86:1281–1288.
  23. Longstreth WT, McGuire V, Koepsell TD, Wang Y, van Belle G: Risk of amyotrophic lateral sclerosis and history of physical activity: A population-based case-control study. Arch Neurol 1998;55:201–206.
  24. Nelson LM, McGuire V, Longstreth WT Jr, Matkin C: Population-based case-control study of amyotrophic lateral sclerosis in western Washington State. I. Cigarette smoking and alcohol consumption. Am J Epidemiol 2000;151:156–163.
  25. Kamel F, Umbach DM, Munsat TL, Shefner JM, Sandler DP: Association of cigarette smoking with amyotrophic lateral sclerosis. Neuroepidemiology 1999;18:194–202.
  26. Kamel 2002 Kamel F, Umbach DM, Munsat TL, Shefner JM, Hu H, Sandler DP: Lead exposure and amyotrophic lateral sclerosis. Epidemiology 2002;13:311–319.
  27. Bergomi M, Vinceti M, Nacci G, Pietrini V, Bratter P, Alber D, Ferrari A, Vescovi L, Guidetti D, Sola P, Malagu S, Aramini C, Vivoli G: Environmental exposure to trace elements and risk of amyotrophic lateral sclerosis: A population-based case-control study. Environ Res 2002;89:116–123.
  28. McGuire V, Longstreth WT Jr, Koepsell TD, van Belle G: Incidence of amyotrophic lateral sclerosis in three counties in western Washington State. Neurology 1996;47:571–573.
  29. Andrews KW, Savitz DA: Accuracy of industry and occupation on death certificates of electric utility workers: Implications for epidemiologic studies of magnetic fields and cancer. Bioelectromagnetics 1999;20:512–518.
  30. Riggs JE, Schochet S Jr: Rising mortality due to Parkinson’s disease and amyotrophic lateral sclerosis: A manifestation of the competitive nature of human mortality. J Clin Epidemiol 1992;45:1007–1012.
  31. Armon C: ALS: Clinical and epidemiologic clues to pathogenesis; in Neurobiology of ALS. Course Syllabus, 51st Annual Meeting, American Academy of Neurology, 1999.
  32. Ambrosone CB, Freudenheim JL, Graham S, Marshall JR, Vena JE, Brasure JR, Michalek AM, Laughlin R, Nemoto T, Gillenwater KA, Shields PG: Cigarette smoking, N-acetyltransferase-2 genetic polymorphisms, and breast cancer risk. JAMA 1996;276:1494–1501.
  33. Seljeseth YM, Vollset SE, Tysnes OB: Increasing mortality from amyotrophic lateral sclerosis in Norway? Neurology 2000;55:1262–1266.
  34. Esclaire F, Kisby G, Spencer P, Milne J, Lesort M, Hugon J: The Guam cycad toxin methylazoxymethanol damages neuronal DNA and modulates τ mRNA expression and excitotoxicity. Exp Neurol 1999;155:11–21.
  35. Kisby GE, Kabel H, Hugon J, Spencer P: Damage and repair of nerve cell DNA in toxic stress. Drug Metab Rev 1999;31:589–618.
  36. Schaeffer MC, Rogers QR, Leung PM, Wolfe BM, Strombeck DR: Changes in cerebrospinal fluid and plasma amino acid concentrations with elevated dietary protein concentration in dogs with portocaval shunts. Life Sci 1991;48:2215–2223.